相关实验视频
Updated: Jan 28, 2026

11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.5K
揭开隐藏的:获得的儿科甲状腺功能低下症
Mariacarolina Salerno1,2, Donatella Capalbo1,3, Mariella Valenzise4
1Department of Translational Medical Sciences, Pediatric Endocrinology Unit, University of Naples Federico II, Naples, Italy.
Frontiers in endocrinology
|January 26, 2026
概括
在儿童中获得的甲状腺功能低下症,通常是由哈希莫托甲状腺炎引起的,呈现出各种症状. 早期诊断和管理对于儿科患者的最佳生长和发育至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 内部医学 内部医学
- 临床案例审查 临床案例审查
背景情况:
- 获得性甲状腺功能低下症是儿童最常见的甲状腺疾病.
- 哈西莫托甲状腺炎是充足地区的主要原因.
- 临床表现不同,使诊断复杂化,并可能影响发育.
研究的目的:
- 总结当前关于儿童获得性甲状腺功能低下症的知识.
- 通过现实生活中的儿科病例来说明典型和非典型的表现.
- 帮助儿科医生识别和管理儿童甲状腺功能低下症.
主要方法:
- 对四个患有获得性甲状腺功能低下症的儿科病例的审查.
- 病因学,临床表现,诊断和管理的全面概述.
- 关于儿科获得性甲状腺功能低下症的文献综合.
主要成果:
- 病例呈现了获得性甲状腺功能低下症的典型和非典型症状.
- 多样化的介绍强调了诊断方面的挑战.
- 及时干预对于儿科结果至关重要.
结论:
- 获得的甲状腺功能低下症需要对儿童进行警的诊断.
- 了解不同的演示文稿有助于儿科医生.
- 有效的管理是防止不良生长和发展影响的关键.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism
212
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
271
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271
Monohybrid Crosses
239.3K
Overview
239.3K
Regulated Protein Degradation
8.8K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K

